David Shelley

549 total citations
15 papers, 439 citations indexed

About

David Shelley is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, David Shelley has authored 15 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in David Shelley's work include Nicotinic Acetylcholine Receptors Study (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Receptor Mechanisms and Signaling (4 papers). David Shelley is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Receptor Mechanisms and Signaling (4 papers). David Shelley collaborates with scholars based in United States, United Kingdom and Chile. David Shelley's co-authors include Mark LeSage, William A. Corrigall, Andrew C. Harris, Jennifer L. Perry, Jason T. Ross, F. Ivy Carroll, Catherine M. Kotz, Katherine E. Manbeck, S. Craig Tuggle and Samuel T. Windham and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Gut.

In The Last Decade

David Shelley

15 papers receiving 434 citations

Peers

David Shelley

PHYSI

CMN

EAS

Lydie Jeandel France

Alda Fernandes United States

Alec J. Jamieson Australia

Xiangpan Kong China

Hsin‐Jung Lee Taiwan

Xuezhu Cai United States

S. Satoh Japan

Yoshimitsu Tokunaga Japan

Yijun Liu China

Katja Tenner Germany

Lydie Jeandel France

David Shelley

241 ×1.1

85 ×0.8

PHYSI

281 ×3.0

CMN

165 ×2.4

EAS

43 ×0.7

Citations per year, relative to David Shelley David Shelley (= 1×) peers Lydie Jeandel

Countries citing papers authored by David Shelley

Since Specialization

Citations

This map shows the geographic impact of David Shelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shelley more than expected).

Fields of papers citing papers by David Shelley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shelley. The network helps show where David Shelley may publish in the future.

Co-authorship network of co-authors of David Shelley

This figure shows the co-authorship network connecting the top 25 collaborators of David Shelley. A scholar is included among the top collaborators of David Shelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shelley. David Shelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lastwika, Kristin J., Joell L. Solan, Yuzheng Zhang, et al.. (2023). Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer. Science Translational Medicine. 15(678). eadd8469–eadd8469. 10 indexed citations

Navarro, Sandi L., Marta Herrero, Yuzheng Zhang, et al.. (2019). Differences in Serum Biomarkers Between Combined Glucosamine and Chondroitin Versus Celecoxib in a Randomized, Double-blind Trial in Osteoarthritis Patients. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 19(2). 190–201. 4 indexed citations

Lastwika, Kristin J., Julia Kargl, Yuzheng Zhang, et al.. (2018). Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules. American Journal of Respiratory and Critical Care Medicine. 199(10). 1257–1266. 25 indexed citations

Lastwika, Kristin J., Julia Kargl, Yuzheng Zhang, et al.. (2018). Abstract A12: Non-small cell lung tumor-derived autoantibodies can distinguish benign from malignant pulmonary nodules. Clinical Cancer Research. 24(17_Supplement). A12–A12. 1 indexed citations

Wang, Xiaoliang, Ali Shojaie, Yuzheng Zhang, et al.. (2017). Exploratory plasma proteomic analysis in a randomized crossover trial of aspirin among healthy men and women. PLoS ONE. 12(5). e0178444–e0178444. 4 indexed citations

Ladd, Jon J., Christopher I. Li, John D. Potter, et al.. (2016). Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut. 67(3). 473–484. 61 indexed citations

Harris, Andrew C., Mark LeSage, David Shelley, et al.. (2015). The Anti-(+)-Methamphetamine Monoclonal Antibody mAb7F9 Attenuates Acute (+)-Methamphetamine Effects on Intracranial Self-Stimulation in Rats. PLoS ONE. 10(3). e0118787–e0118787. 11 indexed citations

Shelley, David, et al.. (2015). A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation. PLoS ONE. 10(12). e0144553–e0144553. 5 indexed citations

Harris, Andrew C., et al.. (2014). Restraint stress attenuates nicotine's locomotor stimulant but not discriminative stimulus effects in rats. Pharmacology Biochemistry and Behavior. 124. 92–100. 8 indexed citations

10.

Manbeck, Katherine E., et al.. (2013). Effects of oxytocin on nicotine withdrawal in rats. Pharmacology Biochemistry and Behavior. 116. 84–89. 41 indexed citations

11.

Stec, Michael J., Anna Thalacker‐Mercer, Samuel T. Windham, et al.. (2013). Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans. Journal of Applied Physiology. 115(6). 937–948. 100 indexed citations

12.

Harris, Andrew C., et al.. (2012). Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine. Psychopharmacology. 225(2). 291–302. 16 indexed citations

13.

LeSage, Mark, David Shelley, Marco Pravetoni, & Paul R. Pentel. (2012). Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist. Pharmacology Biochemistry and Behavior. 102(1). 157–162. 12 indexed citations

14.

LeSage, Mark, Jennifer L. Perry, Catherine M. Kotz, David Shelley, & William A. Corrigall. (2010). Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology. 209(2). 203–212. 70 indexed citations

15.

LeSage, Mark, David Shelley, Jason T. Ross, F. Ivy Carroll, & William A. Corrigall. (2008). Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. Pharmacology Biochemistry and Behavior. 91(3). 461–467. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact